# iShares Biotechnology ETF (0JGB)

**Source:** https://fundology.uk/fund/0jgb · ISIN US4642875565 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 05/10/2026, 0JGB (iShares Biotechnology ETF, ISIN US4642875565) closed at $204.76 on the London Stock Exchange. Its ongoing charge is 0.44% a year (about £44 on £10,000). Over the five years to 05/10/2026 its total return was +34.7%, or +5.3% after UK CPIH inflation.

## Summary

iShares Biotechnology ETF is an exchange-traded fund (ETF) from iShares, launched in 2001. It tracks the NYSE Biotechnology  (TR). You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.44% a year — about £44 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is paid out to holders as cash, usually a few times a year.

> This fund is domiciled outside the UK and EU and does not publish the key information document UK rules require, so most UK platforms do not offer it to retail investors. It is shown for reference.

Latest close: **$204.76** (05/10/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | 0JGB |
| ISIN | US4642875565 |
| Category | Technology |
| Type | ETF |
| Provider | iShares |
| Tracks | NYSE Biotechnology  (TR) |
| Income | Distributing |
| Ongoing charge | 0.44% a year (£44 per £10,000) |
| Fund size | £6.0bn |
| Launched | 2001 |
| Domicile | United States |

## Past returns (periods to 05/10/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +39.75% | +35.36% | income reinvested |
| 3 years | +58.10% | +42.66% | income reinvested |
| 5 years | +34.70% | +5.30% | income reinvested |

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of iShares Biotechnology ETF in pounds (price only, income paid out not included): 2021 −0.3%, 2022 −6.7%, 2023 +0.1%, 2024 −0.4%, 2025 +20.4%; 2026 to 02/10/2026 +20.9%. Returns of iShares Biotechnology ETF in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +52.2%; to 30/09/2025: −4.0%; to 30/09/2024: +8.8%; to 30/09/2023: −4.9%; to 30/09/2022: −15.6%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2021 | -0.3% | -4.9% | Price |
| 2022 | -6.7% | -14.6% | Price |
| 2023 | +0.1% | -3.9% | Price |
| 2024 | -0.4% | -3.8% | Price |
| 2025 | +20.4% | +16.2% | Price |
| 2026 to 02/10/2026 | +20.9% | +17.5% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 20.00% | -7.40% |
| 3 years | 19.67% | -23.57% |
| 5 years | 20.87% | -26.42% |

## Largest fall

Volatility of iShares Biotechnology ETF in pounds, annualised from weekly returns to 02/10/2026: 20.0% over 1 year, 19.7% over 3 years, 20.9% over 5 years. Largest fall in the price of iShares Biotechnology ETF since October 2021, in pounds: −26.4% from 26/11/2021 to 17/06/2022. The lowest 12-month return of iShares Biotechnology ETF in pounds (price only, income paid out not included) since December 2020 was −24.5% (12 months to 17/06/2022); the highest was +51.9% (12 months to 03/07/2026). On 02/10/2026 the price of iShares Biotechnology ETF was 1.8% below its highest weekly close since October 2021 (03/09/2026), in pounds.

## Charges compared with similar funds

Ongoing charge of iShares Biotechnology ETF 0.44% a year, as of 03/10/2026: 73 of the 119 other technology funds charge more, 1 the same and 45 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.44%** per year
- ISA eligible: no
- SIPP eligible: no

## Questions people ask

**What is the ongoing charge of 0JGB?**

The ongoing charge of 0JGB is 0.44% a year — about £44 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of iShares Biotechnology ETF 0.44% a year, as of 03/10/2026: 73 of the 119 other technology funds charge more, 1 the same and 45 less (share classes counted once).

**What does 0JGB track?**

0JGB tracks the NYSE Biotechnology  (TR).

**Is 0JGB accumulating or distributing?**

0JGB is distributing: income is paid out to holders as cash, usually a few times a year. It pays out quarterly.

**What is the ISIN of 0JGB?**

The ISIN of 0JGB is US4642875565. An ISIN identifies one exact share class of a fund; 0JGB is its ticker on the London Stock Exchange.

**What were 0JGB’s returns in each of the last five years?**

Calendar-year returns of 0JGB in pounds (price only, income paid out not included): 2021 −0.3%, 2022 −6.7%, 2023 +0.1%, 2024 −0.4%, 2025 +20.4%; 2026 to 02/10/2026 +20.9%. Past performance is not a guide to future returns.

**How has 0JGB done after inflation?**

Over the five years to 05/10/2026 0JGB’s total return was +34.7%, or +5.3% after UK CPIH inflation. Past performance is not a guide to future returns.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.